119 related articles for article (PubMed ID: 19061202)
1. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
Cypowyj C; Eisinger F; Huiart L; Sobol H; Morin M; Julian-Reynier C
Psychooncology; 2009 Feb; 18(2):209-15. PubMed ID: 19061202
[TBL] [Abstract][Full Text] [Related]
2. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
3. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
[TBL] [Abstract][Full Text] [Related]
4. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
5. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
[TBL] [Abstract][Full Text] [Related]
6. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
7. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
8. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
9. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
[TBL] [Abstract][Full Text] [Related]
10. Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family.
Hallowell N; Arden-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
Sociol Health Illn; 2006 Nov; 28(7):969-88. PubMed ID: 17163862
[TBL] [Abstract][Full Text] [Related]
11. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
[TBL] [Abstract][Full Text] [Related]
12. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
13. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.
d'Agincourt-Canning L
Clin Genet; 2006 Dec; 70(6):462-72. PubMed ID: 17100990
[TBL] [Abstract][Full Text] [Related]
14. [Information spreading about hereditary carriage of a BRCA1/2 mutation and ovarian cancer and rate of consultation of the concerned relatives].
Christophe V; Leroy T; Adenis C; Reich M; Vennin P
Bull Cancer; 2008 Apr; 95(4):395-402. PubMed ID: 18495568
[TBL] [Abstract][Full Text] [Related]
15. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
[TBL] [Abstract][Full Text] [Related]
16. The phases of disclosing BRCA1/2 genetic information to offspring.
Clarke S; Butler K; Esplen MJ
Psychooncology; 2008 Aug; 17(8):797-803. PubMed ID: 18646247
[TBL] [Abstract][Full Text] [Related]
17. Notification of a family history of breast cancer: issues of privacy and confidentiality.
Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
[TBL] [Abstract][Full Text] [Related]
18. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups.
Mellon S; Berry-Bobovski L; Gold R; Levin N; Tainsky MA
Psychooncology; 2006 Mar; 15(3):193-208. PubMed ID: 16100704
[TBL] [Abstract][Full Text] [Related]
19. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Vos J; Otten W; van Asperen C; Jansen A; Menko F; Tibben A
Psychooncology; 2008 Aug; 17(8):822-30. PubMed ID: 18157792
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
